Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Fabrice Chouraqui Steps Down as CEO of Pharming
Published 1 month, 2 weeks ago
Description
New U.S. guidance carves out tariff exemptions for specialty pharmaceuticals, Pharming's Fabrice Chouraqui steps down as CEO amid a board rift, and a dealmaking roundup covers Hengrui Pharma's licensing agreement with Novo Nordisk and AstraZeneca's investment in Summit Therapeutics.